IRIS
BIANCHI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 84.649
AS - Asia 11.759
EU - Europa 8.524
SA - Sud America 1.874
AF - Africa 149
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 34
Totale 107.033
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 84.299
SG - Singapore 6.927
IT - Italia 2.212
CN - Cina 2.038
BR - Brasile 1.586
HK - Hong Kong 1.191
IE - Irlanda 1.124
DE - Germania 1.013
UA - Ucraina 804
RU - Federazione Russa 696
GB - Regno Unito 549
FR - Francia 537
SE - Svezia 436
VN - Vietnam 412
FI - Finlandia 298
PL - Polonia 262
KR - Corea 241
CA - Canada 231
IN - India 212
NL - Olanda 182
JP - Giappone 113
AR - Argentina 110
ID - Indonesia 107
MX - Messico 84
ES - Italia 83
AT - Austria 77
BD - Bangladesh 75
UZ - Uzbekistan 64
TR - Turchia 63
BE - Belgio 59
ZA - Sudafrica 58
EC - Ecuador 52
IQ - Iraq 44
AU - Australia 41
CO - Colombia 34
AE - Emirati Arabi Uniti 30
RO - Romania 30
LT - Lituania 29
MY - Malesia 29
KG - Kirghizistan 26
PK - Pakistan 26
EU - Europa 25
EG - Egitto 22
IL - Israele 22
MA - Marocco 22
PH - Filippine 22
CH - Svizzera 20
CL - Cile 20
CZ - Repubblica Ceca 19
PY - Paraguay 19
VE - Venezuela 19
PE - Perù 18
IR - Iran 17
SA - Arabia Saudita 17
JO - Giordania 15
HU - Ungheria 14
SK - Slovacchia (Repubblica Slovacca) 13
UY - Uruguay 13
PT - Portogallo 12
DK - Danimarca 11
DZ - Algeria 11
GR - Grecia 9
RS - Serbia 9
TN - Tunisia 9
AZ - Azerbaigian 8
PA - Panama 8
TW - Taiwan 8
DO - Repubblica Dominicana 7
KE - Kenya 7
LB - Libano 7
TH - Thailandia 7
KZ - Kazakistan 6
NP - Nepal 6
OM - Oman 6
A2 - ???statistics.table.value.countryCode.A2??? 5
GH - Ghana 5
HR - Croazia 5
SN - Senegal 5
AL - Albania 4
BH - Bahrain 4
GE - Georgia 4
JM - Giamaica 4
BG - Bulgaria 3
BO - Bolivia 3
ET - Etiopia 3
HN - Honduras 3
LK - Sri Lanka 3
LV - Lettonia 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AD - Andorra 2
CR - Costa Rica 2
GI - Gibilterra 2
MN - Mongolia 2
A1 - Anonimo 1
Totale 107.016
Salva come PNG Salva come JPEG
Città #
Wilmington 23.088
Houston 21.903
Woodbridge 17.401
Fairfield 3.253
Singapore 2.543
Ashburn 1.958
Chandler 1.871
Seattle 1.346
Ann Arbor 1.301
Cambridge 1.199
Hong Kong 1.174
Dublin 1.024
Beijing 948
Medford 735
Jacksonville 634
Dearborn 569
Rome 558
Santa Clara 527
New York 456
The Dalles 426
Los Angeles 391
Lawrence 348
Dallas 278
Zhengzhou 257
Buffalo 231
San Diego 223
Menlo Park 200
Council Bluffs 183
Munich 172
Milan 166
Kraków 162
Boardman 159
Moscow 150
São Paulo 145
Ho Chi Minh City 136
Chicago 112
Redwood City 109
London 107
Hanoi 98
Nuremberg 98
Redondo Beach 94
Shanghai 84
Seoul 79
Jakarta 76
Montreal 75
Mülheim 74
Toronto 73
Warsaw 69
Cedarhurst 65
Brooklyn 63
Norwalk 62
Helsinki 61
Tokyo 60
Atlanta 59
Lappeenranta 59
Denver 56
Brussels 55
Guangzhou 54
Chennai 52
Hefei 49
Nanjing 48
Rio de Janeiro 46
Salt Lake City 45
Boston 44
Amsterdam 41
Belo Horizonte 41
Falls Church 40
San Francisco 40
San Mateo 40
Engelhard 38
Johannesburg 37
Stockholm 37
Elk Grove Village 36
Orem 35
Phoenix 34
Florence 33
Naples 33
Verona 32
Mountain View 31
Nanchang 31
Esslingen am Neckar 30
Frankfurt am Main 30
Mexico City 30
Vienna 30
Columbus 28
Poplar 28
Kunming 27
Porto Alegre 27
Redmond 27
Detroit 26
Jinan 25
Manchester 25
San Jose 25
Turku 25
University Park 25
Ankara 23
Brasília 23
Palo Alto 23
Dhaka 21
Haiphong 21
Totale 89.239
Salva come PNG Salva come JPEG
Nome #
Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data 1.625
Crusted scabies in a liver transplant patient mimicking rupioid psoriasis 1.381
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.202
Power Doppler ultrasound assessment of vascularization in hidradenitis suppurativa lesions 747
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors 736
Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis 680
Dermoscopic monitoring of efficacy of Ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas 604
Type I lamellar ichthyosis improved by tazarotene 0.1% gel 561
Is weekly dose of adalimumab a simple approach for resistant psoriasis? 542
Efficacy and safety of infliximab in psoriatic patients over the age of 65 528
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 511
Leflunomide-induced DRESS syndrome 509
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients. 506
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 491
Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy 484
Angiosarcoma cutaneo epitelioide 472
Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis. Data from the Psobiosimilars registry. 472
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. 469
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 465
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 462
Topical lactoferrin can improve stable psoriatic plaque 454
Apremilast for the treatment of psoriasis. 453
Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis 452
Cheratodermia puntata porocheratosica 449
Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial 448
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 447
Treatment of trachyonychia with tazarotene 445
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 443
Psodisk, a new visual method for assessing the burden of psoriasis on patients 443
Tazarotene as alternative topical treatment for onychomycosis 443
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 441
Actinic keratosis treated with an immune response modifier: a case report of six patients 439
Treatment of kerion with fluconazole [30] 433
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 433
Hypodermal Adipose Tissue Sonoelastography for Monitoring Treatment Response in Patients with Plaque Psoriasis 433
Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review 432
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 431
Nails as immune-privileged sites: A case of disabling Acrodermatitis continua of Hallopeau successfully treated with Apremilast 431
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 429
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 427
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 426
Pachydermoperiostosis: Study of epidermal growth factor and steroid receptors 425
Bullous pemphigoid and severe erythrodermic psoriasis: combined low-dose treatment with cyclosporine and systemic steroids 424
Pachydermodactyly: a case of an unusual type of reactive digital fibromatosis 424
Agminated Dermal Melanocytosis in the Territory of Ota's Nevus 423
Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management 421
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. 419
Phrynoderma: a cutaneous sign of an inadequate diet 418
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 418
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 415
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 414
Tildrakizumab for treating psoriasis 414
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 413
Severe erytrodermic psoriasis and arthritis as clinical presentation of a CARD14-mediated psoriasis (CAMPS) 413
Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis 410
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 409
Brodalumab for the treatment of psoriasis 409
Severe acne successfully treated with etanercept 408
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 406
Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features 405
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 405
Non-familial porphyria cutanea tarda: a case report of a rare disease 403
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 401
Stress reactivity in psoriatic patients 400
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 400
Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma 398
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 398
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 397
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 396
Morbid obesity and psoriasis: Disease remission after laparoscopic sleeve gastrectomy 393
Abnormal bcl-2 and 'tissue' transglutaminase expression in psoriatic skin 392
Allergic contact dermatitis of the lip margins from para-tertiary-butylphenol in a lip liner 392
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 392
Psoriasiform sarcoidosis: an unusual variety 390
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients 390
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 388
Elementi di dermatologia 388
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 388
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 387
Cutaneous features of myotonic dystrophy types 1 and 2: implication of premature aging and vitamin d homeostasis 387
Confocal reflectance microscopy in pityriasis rubra pilaris 386
Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections 386
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 382
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 380
Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face 380
Quality-of-life impairment in hidradenitis suppurativa 379
Role of HLA- C*06 in clinical response to ustekinumab: evidence from real-life in a large cohort of European patients. 379
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 379
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 378
Mixoma intramuscolare del volto 376
Erysipeloid cutaneous metastasis from bladder carcinoma 375
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 375
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146 375
Tofacitinib for the treatment of psoriasis 374
Zosteriform metastasis of occult bronchogenic carcinoma 372
The first skin cancer screening day at the Italian parliament: A Euromelanoma initiative 372
Blood MUC-18/MCAM expression in patients with melanoma: A suitable marker of poor outcome 372
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 372
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 372
Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Design, development, and use in therapy 371
Totale 45.987
Salva come PNG Salva come JPEG
Categoria #
all - tutte 288.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 288.739
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.863 0 0 0 0 0 2.087 2.130 1.855 397 620 497 277
2021/20223.947 203 434 264 176 177 306 311 188 263 311 285 1.029
2022/20235.061 489 586 198 612 457 1.114 422 285 465 75 233 125
2023/20242.280 247 69 139 72 183 424 225 183 53 192 93 400
2024/202512.269 332 2.051 1.128 654 250 852 809 560 1.032 967 2.061 1.573
2025/20267.855 1.481 810 2.156 1.558 1.645 205 0 0 0 0 0 0
Totale 109.553